Recommendations from Chemical Sectors

The scrips in this column have been recommended with a 15-day investment horizon in mind and carry high risk. Therefore, investors are advised to take into account their risk appetite before investing, as fundamentals may or may not back the recommendations.[EasyDNNnews:PaidContentStart]

Coromandel International Ltd.
CMP - ₹2,368.30
BSE CODE 506395
Volume 10,679
Face Value ₹1
Target ₹2,557- ₹2,605
Stoploss ₹2,200 (CLS

Coromandel International is a leading Indian agri-solutions company and a flagship of the Murugappa Group. It is the second-largest manufacturer and marketer of phosphate fertilisers in India and a major supplier of crop protection chemicals, specialty nutrients, organic fertilisers and bio-products. The company operates a wide retail network across India, offering agronomic advisory, soil testing and farm services to support farmers throughout the crop cycle. During Q2FY26, the company posted a strong performance, with revenue surging nearly 30 per cent year-on-year to ₹9,654 crore. Profitability also improved, as net profit increased to ₹793 crore compared with ₹659 crore in the corresponding quarter of the previous year. Shares of the company have seen strong buying interest over the past month, resulting in a gain of around 10 per cent. As of September 2025, FIIs have increased their stake in the company by around 4 per cent compared with March 2025. Given its solid fundamentals and the stock’s continued growth potential, we recommend BUY.

Navin Fluorine International Ltd.
CMP - ₹5,704.75
BSE CODE 53250
Volume 22,886
Face Value ₹2
Target ₹6,160 - ₹6,275
Stoploss ₹5,305 (CLS)

Navin Fluorine International Ltd is one of India’s largest and most renowned producers of specialty fluorochemicals. The company manufactures a wide range of products including refrigerants, inorganic fluorides, specialty fluorides and custom fluorinated intermediates through integrated plants. It also provides contract research and manufacturing services for pharmaceutical, agrochemical and specialty chemical clients globally. In Q2FY26, the company reported a strong set of numbers, supported by a 46 per cent year-on-year growth in revenue to ₹758 crore. The bottom line also saw a remarkable turnaround, with net profit soaring 150 per cent to ₹148 crore, compared with ₹59 crore recorded in the corresponding period of the previous year. Shares of the company have demonstrated exceptional resilience, rallying nearly 60 per cent over the past year at a time when many stocks faced sharp corrections amid a weak broader market. Backed by its robust financial performance and a strategically important product portfolio, we recommend BUY.

[EasyDNNnews:PaidContentEnd] [EasyDNNnews:UnPaidContentStart]

[EasyDNNnews:UnPaidContentEnd]